Foamix Expects To Raise $71M In Upcoming NASDAQ IPO

September 7, 2014 | Foam-based drugs developer Foamix announced that it expects to raise $71 million in its upcoming NASDAQ IPO, according to the company prospectus. Additionally, the company noted that it could raise up to $81 million if the underwriters exercise of their options, at a company value of $239 million, after money. The company plans to offer up 6 million shares at a price of between $10-$12 a piece. The underwriters for the offering, scheduled to take place on September 18, are Barclays Investment Bank, Cowen, Oppenheimer, and Maxim group.